{"nctId":"NCT03095508","briefTitle":"Clinical Study for Comparative Assessment of Efficacy and Safety of Angal S, Topical Spray and ANTI-ANGIN® FORMULA, Topical Metered Spray in Treatment of Patients With Uncomplicated Acute Infectious and Inflammatory Diseases of the Pharynx, Accompanied by a Sore Throat","startDateStruct":{"date":"2017-02-22","type":"ACTUAL"},"conditions":["Sore Throat"],"count":229,"armGroups":[{"label":"Angal S (Arm A)","type":"EXPERIMENTAL","interventionNames":["Drug: Angal S, topical spray [Menthol]"]},{"label":"ANTI-ANGIN® FORMULA (Arm B)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: ANTI-ANGIN® FORMULA, topical metered spray"]}],"interventions":[{"name":"Angal S, topical spray [Menthol]","otherNames":[]},{"name":"ANTI-ANGIN® FORMULA, topical metered spray","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Voluntarily signed informed consent for participation in this clinical study;\n* 18 to 45 years old inclusive, male and female;\n* Diagnosed uncomplicated acute infectious and inflammatory diseases of the pharynx, accompanied by a sore throat;\n* Onset of first symptoms of the uncomplicated acute infectious and inflammatory diseases of the pharynx (pharyngitis and/or tonsillitis) less than 48 hours prior to inclusion into the study; Baseline TSS score (Tonsillopharyngitis Severity Score) ≥ 5 (total score);\n* Body temperature 37,5 C (axillary).\n\nExclusion Criteria:\n\n* Use of analgesics within \\<12 hours prior to the study start or/and inability to cancel them during the study;\n* Use of antibiotics within \\<48 hours prior to the study start or/and inability to cancel them during the study;\n* Use of local therapy (sprays, rinses, lozenges) to pharynx within \\<12 hours before study start or/and inability to cancel them, besides study medications;\n* Use systemic or inhaled corticosteroids within ≤1 months prior to the study start and planned therapy of them during the study (besides skin means);\n* Presence of symptoms of primary bacterial pharyngitis or secondary bacterial infection (including fever over 37,5 ° C, the presence of purulent raids in the throat, severe intoxication, leukocytosis, neutrophilia, shift leukocyte left (increasing the percentage of neutrophils sticks appearance younger forms of neutrophils), increased ESR 30 mm/hr).","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"45 Years","stdAges":["ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"SECONDARY","title":"Percentage of Participants With a ≥50% TSS Total Score Reduction","description":"Percentage of participants with a ≥50% TSS Total Score Reduction according to the TSS questionnaire completed by the Investigator as compared to the baseline.\n\nThe Tonsillopharyngitis Severity Score (TSS) scale consists of the following symptoms:\n\nthroat pain, difficulty in swallowing, salivation, erythema and fever rated on a 4-point scale (0 = no symptom to 3 = significant symptom). Total score range from 0 - 15.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"96.49","spread":null},{"groupId":"OG001","value":"98.26","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in TSS Total Score","description":"Change from baseline in TSS total score completed by the Investigator as compared to the baseline.\n\nThe Tonsillopharyngitis Severity Score (TSS) scale consists of the following symptoms:\n\nthroat pain, difficulty in swallowing, salivation, erythema and fever rated on a 4-point scale (0 = no symptom to 3 = significant symptom). Total score range from 0 - 15.","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-6","spread":null},{"groupId":"OG001","value":"-6","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Fully Recovered","description":"Number of Participants who Fully Recovered by Day 4 in Group A and by Day 5 in Group B (the outcome of a disease according to the objective evaluation by the Investigator, the total score according to the TSS questionnaire ≤ 2)","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"106","spread":null},{"groupId":"OG001","value":"107","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in the Sore Throat Intensity by 100 mm VAS","description":"Change in the sore throat intensity by 100 mm VAS (visual analogue scale filled in by the patient) at the start and after 3 days of therapy. The VAS is a 100-mm horizontal line on which the patient's pain intensity is represented by a point between the extremes of \"no pain at all\" and \"worst pain imaginable.\" The VAS ranges from 0 to 100. A decrease from baseline in the VAS score to reflect pain intensity indicates a decrease in pain intensity.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"64.76","spread":"16.29"},{"groupId":"OG001","value":"65.84","spread":"18.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.99","spread":"10.33"},{"groupId":"OG001","value":"5.06","spread":"11.06"}]}]}]},{"type":"SECONDARY","title":"Period of Time Required for Disappearance of the Disease Symptoms","description":"A period of time required for disappearance of the disease symptoms, determined according to the patient's diary (subjective patient's evaluation), but no more than 5 days during the trial-for patients who have achieved the corresponding outcome.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.75","spread":"0.59"},{"groupId":"OG001","value":"3.94","spread":"0.69"}]}]}]},{"type":"PRIMARY","title":"Percentage of Patients Without Sore Throat According to the Tonsillopharyngitis Severity Score (TSS)","description":"The Tonsillopharyngitis Severity Score (TSS) scale consists of the following symptoms:\n\nthroat pain, difficulty in swallowing, salivation, erythema and fever rated on a 4-point scale (0 = no symptom to 3 = significant symptom). Total score range from 0 - 15.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"89.47","spread":null},{"groupId":"OG001","value":"75.65","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.02","spread":null},{"groupId":"OG001","value":"19.13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.63","spread":null},{"groupId":"OG001","value":"4.35","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.88","spread":null},{"groupId":"OG001","value":"0.87","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":114},"commonTop":["Oral discomfort","Abdominal pain upper","Headache","Cough","Throat irritation"]}}}